AMAmany A. Mousa

Amany A. Mousa

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Amany A. Mousa has a total of 22 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Iron overload detection using pituitary and hepatic MRI in thalassemic patients having short stature and hypogonadism

    by Amany A. Mousa, Mohamed Ghonem, El Hadidy M. Elhadidy, Emad Azmy, Magda Elbackry, Azza A. Elbaiomy, Rasha R. Elzehery, Gehan A. Shaker, Omyma Saleh

    Objective: to assess the growth and pubertal development among a group of patients with β-Thalassemia Major (β-TM) and to evaluate the role of the pituitary gland and liver MRI signal intensity (SI) reduction in assessing and predicting the clinical severity of growth and pubertal dysfunctions. Methods: Thirty-eight patients with β-TM were examined and divided into two groups: Group I patients were of normal height and puberty and Group II patients had short statures and hypogonadism. Laboratory investigations included serum ferritin, LH, FSH, prolactin, TSH, and basal and dynamic growth hormones. Pituitary and liver MRIs were performed to assess the pituitary to fat (P/F) and liver to muscle (L/M) signal intensities (SI), respectively. Fifteen healthy and sex- and age-matched subjects were included as controls. Results: Both patient groups had significantly elevated serum ferritin and significantly decreased prolactin and IGF1 compared to control subjects. Group II showed a significant reduction in LH, FSH, and IGF1 and a significant increase in ferritin in comparison with Group I and the control group, and it had a highly significant reduction in both P/F and L/M SI in comparison with Group I (p<0.001 and 0.008, respectively). The reduced P/F ratio was significantly correlated with FSH and LH, and a cutoff for a P/F ratio ≥0.94 was obtained to differentiate between Group I and II. Conclusion: MRI in conjunction with the P/F signal intensity ratio is a useful and noninvasive tool for the early diagnosis of pituitary iron overload.


  • Open Access

    Renal Resistive Index and Urinary N-acetyl-?-glucosaminidase as Predictors of Early Renal Involvement in Patients WithEssential Hypertension

    by Amany Mousa, Amany A Mousa, Mervat M El-Eshmawy, Eman H El-Adawy, Lamiaa F Arafa, Adel El Badrawy, Omayma M Saleh

    Background: The long-standing essential hypertension causes renal injury. N-acetyl-beta-glucosaminidase (NAG) was considered as an indicator of the functional status of the renal tubules. The resistive index (RI), measured at the level of the interlobar arteries, is thought to reflect downstream vascular impedence and therefore, has been suggested as a measure of renal arterial stiffness. The aim of this study was to investigate whether changes in renal function assessed by urinary N-acetyl-beta-glucosaminidase (NAG) and proteinurea are present in hypertensive patients with normal serum creatinine and the association of these changes with renal vascular resistance assessed by ultrasound Doppler. Methods: The study enrolled 78 patients with essential hypertension and 57 age- and sex-matched normotensive subjects. BMI, creatinine, creatinine clearance, uric acid, lipid profile, total proteins, NAG and creatinine in urine were assessed. RI was evaluated by ultrasound Doppler of the interlobar arteries. Results: Hypertensive patients had significantly higher urinary excreted NAG, total urinary proteins and RI than controls. RI was significantly correlated with age, systolic blood pressure, hypertension duration, total proteins, total cholesterol, excreted NAG and creatinine clearance. In multivariate analysis RI was significantly and independently influenced by NAG and creatinine clearance. Conclusion: Early glomerular and tubular dysfunctions precede the overt changes in serum creatinine and glomerular filtration rate in hypertensive patients. Resistive index is increased along with these abnormalities. So, it should be regarded as a marker of early renal and systemic vascular damage and could help identify hypertensive patients for whom more aggressive preventive and therapeutic measures are advisable. doi:10.4021/wjnu2w

  • Open Access

    Elevated serum neutrophil elastase is related to prehypertension and airflow limitation in obese women

    by Mervat M El-Eshmawy, Eman H El-Adawy, Amany A Mousa, Amany E Zeidan, Azza A El-Baiomy, Elham R Abdel-Samie, Omayma M Saleh

    Background: Neutrophil elastase level/activity is elevated in a variety of diseases such as atherosclerosis, systolic hypertension and obstructive pulmonary disease. It is unknown whether obese individuals with prehypertension also have elevated neutrophil elastase, and if so, whether it has a deleterious effect on pulmonary function. Objectives: To determine neutrophil elastase levels in obese prehypertensive women and investigate correlations with pulmonary function tests. Methods: Thirty obese prehypertensive women were compared with 30 obese normotensive subjects and 30 healthy controls. The study groups were matched for age. Measurements: The following were determined: body mass index, waist circumference, blood pressure, lipid profile, high sensitivity C-reactive protein, serum neutrophil elastase, and pulmonary function tests including forced expiratory volume in one second (FEV1), forced vital capacity (FVC) and FEV1/FVC ratio. Results: Serum neutrophil elastase concentration was significantly higher in both prehypertensive (405.8 ± 111.6 ng/ml) and normotensive (336.5 ± 81.5 ng/ml) obese women than in control non-obese women (243.9 ± 23.9 ng/ml); the level was significantly higher in the prehypertensive than the normotensive obese women. FEV1, FVC and FEV1/FVC ratio in both prehypertensive and normotensive obese women were significantly lower than in normal controls, but there was no statistically significant difference between the prehypertensive and normotensive obese women. In prehypertensive obese women, there were significant positive correlations between neutrophil elastase and body mass index, waist circumference, systolic blood pressure, diastolic blood pressure, total cholesterol, triglyceride, low density lipoprotein cholesterol, high sensitivity C-reactive protein and negative correlations with high density lipoprotein cholesterol, FEV1, FVC and FEV1/FVC. Conclusion: Neutrophil elastase concentration is elevated in obese prehypertensive women along with an increase in high sensitivity C-reactive protein which may account for dyslipidemia and airflow dysfunction in the present study population.


  • Open Access

    The potential therapeutic effect of melatonin in gastro-esophageal reflux disease

    by Tharwat S Kandil, Amany A Mousa, Ahmed A El-Gendy, Amr M Abbas

    Gastro-Esophageal Reflux Disease (GERD) defined as a condition that develops when the reflux of stomach contents causes troublesome symptoms and/or complications. Many drugs are used for the treatment of GERD such as omeprazole (a proton pump inhibitor) which is a widely used antiulcer drug demonstrated to protect against esophageal mucosal injury. Melatonin has been found to protect the gastrointestinal mucosa from oxidative damage caused by reactive oxygen species in different experimental ulcer models. The aim of this study is to evaluate the role of exogenous melatonin in the treatment of reflux disease in humans either alone or in combination with omeprazole therapy.